Aska PharmaceuticalLtd. (4886.TSE) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
35
41
47
54

Details

Expected EPS
N/A
Actual EPS
36
Surprise EPS
36
Surprise Percent
+∞%

Description

Aska PharmaceuticalLtd. (4886.TSE) has reported earnings of 36 per share for Q4 2025.

0 Comments

Share your thoughts